XML 80 R7.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
At The Market Sales Agreement
January2024 P I P E Transaction
Common Stock
Common Stock
At The Market Sales Agreement
Common Stock
January2024 P I P E Transaction
Additional Paid-in Capital
Additional Paid-in Capital
At The Market Sales Agreement
Additional Paid-in Capital
January2024 P I P E Transaction
Accumulated Other Comprehensive Income
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2022       39,307,286              
Beginning balance at Dec. 31, 2022 $ 113,684     $ 4     $ 427,925     $ 3,035 $ (317,280)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net loss (93,612)                   (93,612)
Foreign exchange translation adjustment 724                 724  
Stock-based compensation 7,102           7,102        
Shares issued from exercise of pre-funded warrants (in shares)       5,096,552              
Shares issued from the exercise of pre-funded warrants 51           51        
Issuance of common stock (in shares)         657,012            
Issuance of common stock   $ 853           $ 853      
Shares issued in connection with the Company's employee stock purchase plan (in shares)       116,880              
Shares issued in connection with the Company's employee stock purchase plan $ 129           129        
Ending balance (in shares) at Dec. 31, 2023 45,177,730     45,177,730              
Ending balance at Dec. 31, 2023 $ 28,931     $ 4     436,060     3,759 (410,892)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net loss (100,507)                   (100,507)
Foreign exchange translation adjustment 450                 450  
Stock-based compensation 8,527           8,527        
Issuance of common stock (in shares)         150,000 44,751,286          
Issuance of common stock   $ 191 $ 52,364     $ 4   $ 191 $ 52,360    
Conversion of tranche rights liability to equity 28,396           28,396        
Shares issued in connection with the Company's employee stock purchase plan (in shares)       71,853              
Shares issued in connection with the Company's employee stock purchase plan $ 77           77        
Ending balance (in shares) at Dec. 31, 2024 90,150,869     90,150,869              
Ending balance at Dec. 31, 2024 $ 18,429     $ 8     $ 525,611     $ 4,209 $ (511,399)